SAN DIEGOT Allele Biotechnology & Pharmaceuticals Inc. has received issuance notices from the U.S. Patent and Trademark Office for its first batch of patents covering the derivation of induced pluripotent stem cells (iPSCs). Allele’s proprietary technology uses only messenger RNA (mRNA) to reprogram human or other primate cells, avoiding many operational complications that other methods […]
Agilent OnePGT solution empowers fertility specialists to attain comprehensive insights to improve the ranking of in vitro fertilized (IVF) embryos SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced the introduction of Agilent OnePGT, a genome-wide, next-generation sequencing (NGS) solution for preimplantation genetic testing (PGT). OnePGT allows parallel detection of multiple monogenic disorders (PGT-M), […]
COLOGNE, Germany & LEIDEN, Netherlands & CAMBRIDGE, England–Ncardia, a leader in human iPSC-based solutions for drug safety and efficacy screening, and Horizon Discovery Group plc (LSE:HZD) (Horizon), a global leader in gene editing and gene modulation technologies, announced a partnership to provide custom genetically modified and differentiated human iPSC-derived cells (hiPSC) for drug discovery researchers. […]
Illumina Launches TruSight Oncology 500 to Power Comprehensive, Accurate, Pan-Cancer Tumor Profiling
SAN DIEGO— Illumina, Inc. (NASDAQ: ILMN) today announces the launch of TruSightTM Oncology 500 (TSO 500), a comprehensive pan-cancer assay designed to identify known and emerging tumor biomarkers. TruSight Oncology 500 utilizes both DNA and RNA from subject tumor samples to identify key somatic variants underlying tumor progression, such as small DNA variants, fusions, and splice variants. Importantly, […]
SAN FRANCISCO–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that it has priced its initial public offering of 5,000,000 shares of its common stock at a price to the public of $14.00 per share, before underwriting discounts and commissions. All of the shares of common stock are […]
SALT LAKE CITY–Privately held XCR Diagnostics Inc. and Luminex Corporation (Nasdaq:LMNX) have entered into a non-exclusive, worldwide license agreement for XCR’s proprietary Xtreme Chain Reaction nucleic acid amplification technology. The XCR technology enables extremely rapid thermal cycling protocols to achieve dramatically reduced assay turnaround times compared to traditional polymerase chain reaction. Financial terms were not disclosed. “XCR […]
ITHACA, N.Y.—Rheonix, Inc. announces the launch of its NGS OnePrep™ solution, an integrated, automated method for DNA extraction and next-generation sequencing (NGS) library preparation on the Encompass Optimum™ workstation, at the Association of Molecular Pathology (AMP) Annual Meeting and Expo Nov.1-3 in San Antonio, Texas. The method will allow laboratory technicians to produce sequence-ready libraries […]
HERCULES, Calif. — A recent study published online in the Journal of Molecular Diagnostics demonstrated that Droplet Digital PCR (ddPCR) technology can be used to detect mutations in a region of our DNA that is linked to many cancer types, paving the way for the development of new cancer diagnostics and therapies. Two mutations in the promoter region of […]
Co-Diagnostics agrees to license CoPrimers™ for use in agricultural applications SALT LAKE CITY–Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests, and LGC, Biosearch Technologies, a global leader in the design, development, and manufacture of sophisticated, custom oligonucleotide-based tools and associated reagents for applied markets, announced […]
Translational Research Initiative Will Use PanCancer IO 360 Panel to Identify Predictive Signatures for MGD013 SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that MacroGenics(NASDAQ:MGNX) and NanoString have entered into a translational research agreement to identify and develop biomarkers for MacroGenics’ MGD013 program. MGD013 is an IgG4κ bispecific […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
